Cardlytics, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
Cardlytics reports a significant net loss and revenue decline in Q3 2025, driven by a substantial goodwill impairment and reduced billings, alongside a workforce reduction plan.
NASDAQ
Cardlytics reports a decline in Q2 2025 revenue and billings, alongside a significant non-renewal notice from Bank of America, while extending its JPMorgan Chase partnership.
NASDAQ
Cardlytics' Q1 2025 results reveal a revenue decrease, influenced by shifts in pricing models and the decommissioning of the Dosh app, alongside strategic financial maneuvers.
NASDAQ
Cardlytics' Q3 2024 results reveal a significant goodwill impairment charge impacting overall profitability, despite some growth in user base.
NASDAQ
Cardlytics' Q2 results show a decrease in revenue despite an increase in billings, influenced by higher consumer incentives and strategic debt management.
NASDAQ
Cardlytics' first quarter of 2024 saw a slight revenue increase alongside strategic debt management and equity offerings.